1. Home
  2. FR vs PRAX Comparison

FR vs PRAX Comparison

Compare FR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Industrial Realty Trust Inc.

FR

First Industrial Realty Trust Inc.

N/A

Current Price

$58.89

Market Cap

8.2B

Sector

Real Estate

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$288.69

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FR
PRAX
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FR
PRAX
Price
$58.89
$288.69
Analyst Decision
Buy
Strong Buy
Analyst Count
17
19
Target Price
$72.25
★ $638.68
AVG Volume (30 Days)
★ 819.0K
357.8K
Earning Date
10-14-2026
11-04-2026
Dividend Yield
★ 3.36%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.66
N/A
Revenue
★ $727,076,000.00
N/A
Revenue This Year
$8.07
N/A
Revenue Next Year
$6.68
$39,590.54
P/E Ratio
$36.55
★ N/A
Revenue Growth
★ 8.58
N/A
52 Week Low
$50.29
$50.31
52 Week High
$69.88
$392.70

Technical Indicators

Market Signals
Indicator
FR
PRAX
Relative Strength Index (RSI) 27.51 35.63
Support Level $58.87 $282.35
Resistance Level $60.50 $354.17
Average True Range (ATR) 0.88 14.63
MACD -0.15 -1.65
Stochastic Oscillator 3.27 21.96

Price Performance

Historical Comparison
FR
PRAX

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: